Sex (Female) | 19 (37.2 %) |
---|---|
Age (years) | 68.3 (61.4–76) |
  Diabetes | 16 (31.3 %) |
  Hyperlipidemia | 24 (47.1 %) |
  Hypertension | 36 (70.6 %) |
  Atrial fibrilation | 7 (13.7 %) |
  ASPECTS | 10 (7–10) |
  9–10 | 27 (52.9 %) |
  8 or less | 24 (47.1 %) |
Occlusion type | |
  Atherosclerotic | 38 (74.5 %) |
  Dissection | 13 (25.5 %) |
  Tandem lesion | 42 (82.3 %) |
  Preprocedural therapy | 21 (41.1 %) |
  Intraprocedural therapy | 18 (35.3 %) |
Postprocedural therapy | |
  ASA | 15 (29.4 %) |
  ASA + Clopidogrel | 33 (64.7 %) |
  Heparin/none | 3 (5.9 %) |
  Hemorragic transformation | 10 (19.6 %) |
  Procedure time (minutes) | 69 (46–90) |
Extracranial technique | |
  PTA | 18 (35.3 %) |
  Stent | 6 (11.8 %) |
  PTA + Stent | 15 (29.4 %) |
  None/other | 12 (23.5 %) |
Intracranial technique | |
  ADAPT | 28 (54.9 %) |
  Solumbra | 11 (21.6 %) |
  Retriever | 2 (3.9 %) |
  None | 10 (19.6 %) |
  Stent placement | 21 (41.1 %) |